Skip to main content
Figure 1 | International Journal of Pediatric Endocrinology

Figure 1

From: Characteristics of children with the best and poorest first- and second-year growth during rhGH therapy: data from 25 years of the Genentech national cooperative growth study (NCGS)

Figure 1

Distribution of responses based on height velocity standard deviation score (HV SDS) of patients with idiopathic growth hormone deficiency (IGHD) and idiopathic short stature (ISS) in the second year of therapy based on their category of response during the first year. HV SDS responses to recombinant human growth hormone of patients with IGHD (A) and ISS (B) in the first year of therapy and subsequent second-year response. The pie segments (a) represent the distribution of patients into the 3 first-year growth velocity groups; < −1 SDS, -1 to +1 SDS, >1 SDS. The three charts, b, c, and d, show the SDS shift in the second year of each of the 3 first-year growth velocity groups.

Back to article page